<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 06-1397316
-------------------------------------- ------------------------
(State or Other Jurisdiction (IRS Employer
of Incorporation) Identification No.)
251 BALLARDVALE STREET, WILMINGTON, MA 01887
-------------------------------------- ------------------------
(Address of Principal Executive Offices) (Zip Code)
If this Form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box. /X/
If this Form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), please check the following box. / /
Securities Act registration statement file number to which this form relates:
333-35524
---------------
(If applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
---------------------------- ----------------------------------
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
COMMON STOCK, $.01 PAR VALUE NEW YORK STOCK EXCHANGE
Securities to be registered pursuant to Section 12(g) of the Act:
NONE
-------------------------
(Title of class)
Page 1 of 3
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
COMMON STOCK, $.01 PAR VALUE
The capital stock of Charles River Laboratories International, Inc. (the
"Company") to be registered on the New York Stock Exchange, Inc. (the
"Exchange") is the Company's Common Stock, par value $.01 per share (the "Common
Stock").
The description of the Company's Common Stock is set forth in the
information provided under "Description of Capital Stock" in the prospectus
which forms a part of Amendment No. 1 to the Registration Statement on Form S-1
(File Number 333-35524) filed under the Securities Act of 1933 with the
Securities and Exchange Commission on June 6, 2000 (as amended from time to
time, the "Registration Statement"), which information is incorporated herein by
reference.
Capitalized terms used herein and not otherwise defined have the meanings
assigned to them in the Registration Statement.
ITEM 2. EXHIBITS.
None.
Page 2 of 3
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
By: /s/ Dennis R. Shaughnessy
-------------------------------------------------
Name: Dennis R. Shaughnessy
Title: Senior Vice President and General Counsel
Dated: June 6, 2000
Page 3 of 3
